Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children

• Status: Completed
• Trial end date: 2017-10-30
• Target enrollment: 0
• Participant gender: All

Summary

To analyze the efficacy of beraprost and sildenafil for treatment of pulmonary hypertension in children with left to right shunt.

analyze the efficacy and side effects.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dr. Soetomo General Hospital
• Treatments: Beraprost; Citric Acid; Epoprostenol; Sildenafil Citrate

Criteria

Inclusion Criteria:

• diagnosed as pulmonary hypertension with left to right shunt CHD (VSD, ASD, PDA and combination)

• agree to enroll in this study

Exclusion Criteria:

• suffer from chronic lung disease

• suffer from soft tissue tumor, HIV/AIDS

• under interferon therapy

• already performed any cardiac surgery

• already got anti-PH remedy